311 related articles for article (PubMed ID: 18316258)
1. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy.
Reginster JY; Collette J; Neuprez A; Zegels B; Deroisy R; Bruyere O
Bone; 2008 May; 42(5):832-6. PubMed ID: 18316258
[TBL] [Abstract][Full Text] [Related]
2. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?
Bonnick SL; Shulman L
Am J Med; 2006 Apr; 119(4 Suppl 1):S25-31. PubMed ID: 16563938
[TBL] [Abstract][Full Text] [Related]
3. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of bone health and osteoporosis risk.
Eastell R; Hannon RA
Proc Nutr Soc; 2008 May; 67(2):157-62. PubMed ID: 18412989
[TBL] [Abstract][Full Text] [Related]
5. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
6. Is bone mineral density predictive of fracture risk reduction?
Cefalu CA
Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
[TBL] [Abstract][Full Text] [Related]
7. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
Seeman E
Bone; 2007 Sep; 41(3):308-17. PubMed ID: 17644058
[TBL] [Abstract][Full Text] [Related]
8. Is there a place for bone turnover markers in the assessment of osteoporosis and its treatment?
Devogelaer JP; Boutsen Y; Gruson D; Manicourt D
Rheum Dis Clin North Am; 2011 Aug; 37(3):365-86, v-vi. PubMed ID: 22023897
[TBL] [Abstract][Full Text] [Related]
9. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
10. Selection of antiresorptive or anabolic treatments for postmenopausal osteoporosis.
Papapoulos S; Makras P
Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):514-23. PubMed ID: 18714329
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of biochemical markers of bone turnover in diagnosis of osteoporosis].
Pluskiewicz W; Stempniewicz E
Przegl Lek; 1994; 51(3):149-51. PubMed ID: 8058983
[TBL] [Abstract][Full Text] [Related]
12. The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis.
Szulc P
Clin Biochem; 2012 Aug; 45(12):907-19. PubMed ID: 22330940
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.
Palomba S; Manguso F; Orio F; Russo T; Oppedisano R; Sacchinelli A; Falbo A; Tolino A; Zullo F; Mastrantonio P
Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280
[TBL] [Abstract][Full Text] [Related]
14. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
Wada S; Fukawa T; Kamiya S
Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
[TBL] [Abstract][Full Text] [Related]
15. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.
Reid DM; Hosking D; Kendler D; Brandi ML; Wark JD; Marques-Neto JF; Weryha G; Verbruggen N; Hustad CM; Mahlis EM; Melton ME
Int J Clin Pract; 2008 Apr; 62(4):575-84. PubMed ID: 18324951
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of serum and urine bone markers in the management of osteoporosis.
Srivastava AK; Vliet EL; Lewiecki EM; Maricic M; Abdelmalek A; Gluck O; Baylink DJ
Curr Med Res Opin; 2005 Jul; 21(7):1015-26. PubMed ID: 16004668
[TBL] [Abstract][Full Text] [Related]
18. The value of biochemical markers of bone turnover in osteoporosis.
Eastell R; Blumsohn A
J Rheumatol; 1997 Jun; 24(6):1215-7. PubMed ID: 9195539
[TBL] [Abstract][Full Text] [Related]
19. [The impact of statin therapy on bone density changes in postmenopausal women].
Svejda P; Soska V; Soucek M
Vnitr Lek; 2007 Oct; 53(10):1064-70. PubMed ID: 18072431
[TBL] [Abstract][Full Text] [Related]
20. [Biochemical markers of bone turnover: Serum P1NP].
Imanishi Y; Nishizawa Y
Nihon Rinsho; 2007 Nov; 65 Suppl 9():231-5. PubMed ID: 18161111
[No Abstract] [Full Text] [Related]
[Next] [New Search]
